News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Daily News Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2 Yael L. Maxwell November 03, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Daily News Study Touts Benefits of Exercise as Primary CVD Prevention in Older Adults L.A. McKeown February 15, 2022
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19 Michael O'Riordan August 28, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Daily News COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill Michael O'Riordan May 19, 2020
News Daily News Stroke After PCI: Rare but Rising as Patient Complexity Climbs Todd Neale August 05, 2019
News Daily News Trial Points to Possible Benefit of Intensive BP-Lowering to Stave Off Recurrent Stroke Todd Neale July 29, 2019
News Daily News HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR L.A. McKeown March 13, 2019
News Daily News Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests L.A. McKeown May 23, 2018